Silo Pharma, Inc. financial data

Symbol
SILO on Nasdaq
Location
Sarasota, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 549 % -27.8%
Debt-to-equity 38.89 % +32.9%
Return On Assets -77.07 % -59.4%
Operating Margin -7,361 % -30.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13,318,273 shares +2%
Common Stock, Shares, Outstanding 10,461,130 shares +1.3%
Entity Public Float 3,431,092 USD -42.5%
Common Stock, Value, Issued 1,046 USD +1.3%
Weighted Average Number of Shares Outstanding, Basic 9,331,346 shares +1.2%
Weighted Average Number of Shares Outstanding, Diluted 9,331,346 shares +1.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 72,102 USD 0%
Cost of Revenue 25,066 USD +3.3%
Research and Development Expense 2,994,368 USD +91.3%
Operating Income (Loss) -5,307,490 USD -30.9%
Nonoperating Income (Expense) 230,702 USD -32.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5,076,788 USD -36.7%
Income Tax Expense (Benefit) 906,396 USD +50.3%
Net Income (Loss) Attributable to Parent -5,076,788 USD -34.2%
Earnings Per Share, Basic 0 USD/shares +22.7%
Earnings Per Share, Diluted 0 USD/shares +22.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3,917,627 USD -19.4%
Assets, Current 6,164,369 USD -25.4%
Intangible Assets, Net (Excluding Goodwill) 220,312 USD -9.8%
Assets 6,384,681 USD -25.5%
Accounts Payable, Current 143,607 USD
Contract with Customer, Liability, Current 72,102 USD 0%
Liabilities, Current 708,339 USD -32.2%
Contract with Customer, Liability, Noncurrent 667,502 USD -9.7%
Liabilities 1,375,841 USD -22.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 11,345 USD -42.7%
Retained Earnings (Accumulated Deficit) -18,610,859 USD -37.5%
Stockholders' Equity Attributable to Parent 5,008,840 USD -26.1%
Liabilities and Equity 6,384,681 USD -25.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1,640,300 USD -95.7%
Net Cash Provided by (Used in) Financing Activities -115,452 USD
Net Cash Provided by (Used in) Investing Activities 871,381 USD +7.9%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 10,461,130 shares +1.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3,917,627 USD -19.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2,066 USD +10.5%
Deferred Tax Assets, Valuation Allowance 3,710,726 USD +46.2%
Deferred Tax Assets, Gross 3,710,726 USD +46.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5,085,240 USD -35.1%
Lessee, Operating Lease, Liability, to be Paid 1,878,928 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1,878,928 USD
Deferred Tax Assets, Operating Loss Carryforwards 2,958,758 USD +25.6%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital 23,607,308 USD +16.3%
Amortization of Intangible Assets 3,092 USD
Deferred Tax Assets, Net of Valuation Allowance 2,538,565 USD +63.7%
Share-based Payment Arrangement, Expense 0 USD
Interest Expense 5,084 USD +13%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%